Ilumya (tildrakizumab-asmn) Injection Therapy

Targeted Biologic Therapy for Moderate to Severe Plaque Psoriasis

Clearwell Infusion Centers offers safe, professional administration of Ilumya (tildrakizumab-asmn) for patients with moderate to severe plaque psoriasis. As a trusted injection and infusion center in Miami, we provide private suites, flexible scheduling, and compassionate, patient-first care for chronic inflammatory skin conditions.

What Is Ilumya?

Ilumya® (tildrakizumab-asmn) is an FDA-approved biologic injection for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It works by targeting interleukin-23 (IL-23), a key inflammatory cytokine involved in psoriasis development.

Ilumya is administered as a subcutaneous injection once every 12 weeks after two starter doses at weeks 0 and 4. This long-acting dosing schedule makes it a convenient option for ongoing plaque psoriasis management.

Conditions Treated with Ilumya

Ilumya is indicated for:

• Moderate to severe plaque psoriasis in adults

It may be prescribed for patients who haven’t responded well to topical therapies or who prefer a less frequent injection schedule.

Ilumya Side Effects

Ilumya is generally well tolerated, but as with any biologic therapy, side effects can occur. Common side effects include:

• Upper respiratory infections
• Injection site reactions (pain, redness, swelling)
• Diarrhea
• Headache

Rare but serious risks include hypersensitivity reactions and increased risk of infections. Patients should be screened for tuberculosis prior to starting treatment. For a full list of potential side effects, visit the Ilumya website and review the prescribing information.

Why Choose Clearwell for Your Ilumya Injections?

At Clearwell Infusion Centers in Miami, we provide a comfortable, supportive setting for long-term biologic therapy. When you receive Ilumya at Clearwell, you benefit from:

• Private, spa-like injection suites
• Low patient-to-provider ratios for attentive care
• ACHC-accredited clinical and safety protocols
• Flexible appointment times, including evenings and weekends
• Full insurance support, including prior authorization and benefits verification

Our experienced team ensures every injection is administered safely and on schedule.

Getting Started with Ilumya Treatment

If you’ve been diagnosed with moderate to severe plaque psoriasis and prescribed Ilumya, Clearwell Infusion Centers will coordinate with your dermatologist or provider, confirm insurance coverage, and help you get started quickly.

Questions? Call us at 305‑306‑7147 or email contact@clearwellinfusion.com.

Referring Providers: Partner with Clearwell Infusion Centers

Clearwell Infusion Centers partners with dermatologists, rheumatologists, and primary care physicians to administer Ilumya safely in a fully accredited outpatient setting.

Why refer your patients to Clearwell?

• Fast insurance approvals and benefits checks
• Streamlined referral process with same-week availability
• Timely documentation and follow-up shared with your office
• FDA-approved Ilumya administered by trained clinical staff
• ACHC-accredited, safety-first operational protocols

To refer a patient for Ilumya therapy in Miami, contact our provider team at referrals@clearwellinfusion.com or call 305‑306‑7147.

Looking to start your Ilumya treatment at Clearwell Infusion Centers?

Fill out the form below and a member of our team will contact you